
Health Outcomes Analysis Framework
Design and validate rigorous health outcomes analyses with regulatory compliance
What You Can Do
You can design statistically sound health outcomes analyses that meet regulatory standards for clinical research. This skill helps you document complete analysis plans, identify statistical assumptions, validate study designs, and generate regulatory-ready protocols. Each analysis includes automatic compliance checks to ensure your study meets FDA, ICH, or other relevant regulatory requirements.
Features
Generate comprehensive statistical analysis protocols that outline your study design, primary and secondary outcomes, statistical methods, sample size calculations, and analysis populations.
Automatically validate your analysis plan against FDA 21 CFR Part 11, ICH-GCP, and other regulatory standards to ensure compliance before study execution.
Identify and document all assumptions underlying your chosen statistical methods, including distribution assumptions, independence requirements, and homogeneity conditions.
Create detailed, peer-review-ready documentation of your statistical approach with justifications for each method, sample size rationale, and planned sensitivity analyses.
Determine appropriate sample sizes based on your primary outcome, effect size, power, alpha level, and population characteristics with full methodological justification.
Design rigorous subgroup analyses that minimize false discovery while maintaining statistical power for meaningful patient stratification.
Develop and document missing data handling strategies including sensitivity analyses, assumptions validation, and regulatory rationale.
Example Output
Example 1: Analysis Protocol Outline
Study: CARDIO-2024 Phase III Efficacy Trial
## Primary Analysis Population
- Intent-to-treat (ITT): N=450, all randomized participants
- Per-protocol (PP): N=420, ≥80% protocol adherence
## Primary Outcome
- Change in LDL-C from baseline to Week 12
- Planned analysis: ANCOVA with baseline LDL-C as covariate
- Primary efficacy threshold: p < 0.05 (two-sided)
## Sample Size Justification
- Expected effect: 30 mg/dL reduction (SD=45)
- Power: 90% at alpha=0.05 (two-sided)
- Required N: 346 per arm; 450 total with 20% attrition
Example 2: Regulatory Compliance Checklist
- ✓ Primary endpoint clearly defined with pre-specified statistical test
- ✓ Secondary endpoints listed with multiplicity adjustment plan
- ✓ Missing data handling strategy documented and justified
- ✓ Subgroup analyses pre-specified with multiple testing adjustment
- ✓ Sensitivity analyses planned for key modeling assumptions
- ✓ Analysis populations clearly defined (ITT, PP, safety)
Example 3: Statistical Assumptions Assessment
Planned Test: Two-way ANCOVA
Required Assumptions:
✓ Normality: Q-Q plot inspection planned
✓ Homogeneity: Levene's test at α=0.05
✓ Homogeneity of slopes: Interaction term tested
✓ Independence: Verified by study design (randomization)
What's Included
- Statistical Analysis Plan Template: Pre-formatted template covering design, populations, endpoints, analysis methods, sample size rationale, and assumptions.
- Regulatory Compliance Checklist: FDA, ICH-GCP, and 21 CFR Part 11 aligned checklist ensuring all regulatory requirements are addressed before protocol submission.
- Assumption Validation Framework: Systematic approach to identifying, documenting, and testing all statistical assumptions underlying your planned analyses.
- Sample Size Calculation Guide: Step-by-step methodology for determining appropriate sample sizes with full justification of power, effect size, and statistical rationale.
- Missing Data Strategy Toolkit: Templates and frameworks for developing missingness assumptions, imputation strategies, and sensitivity analyses with regulatory justification.
Who It's For
- Biostatisticians
- Clinical researchers and principal investigators
- Regulatory affairs specialists
- Study protocol writers and coordinators
- Clinical trial managers
Best For
- Designing phase II/III clinical trial protocols
- Pre-specifying statistical analysis plans (SAPs)
- Preparing regulatory submissions with statistical rigor
- Validating study designs and sample size justifications
- Documenting compliance with regulatory standards







